Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer’s partnership with Parexel and transition to a functional service provider (FSP) model.
Related Posts
5 essential capabilities for decentralized clinical trials (DCT)
July 30th 2024 Article Do you leverage a quality-first mindset as you evaluate clinical trial technology? When you evaluate eCOA…
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
Credit: Juan Gärtner | stock.adobe.com Results of the multinational Phase II eNRGy trial (NCT02912949) show that zenocutuzumab (Bizengri) produced durable…
DVCR’s Multi-Site Model
Korey Nevitt (Executive Director, Site Partnerships) talked with ACT about what makes Dr. Vince Clinical Research (DVCR) solutions for clinical…